Summary

Recent developments in genomic analysis and advances in bioinformatics have enabled the adoption of more personalized treatment approaches, such as neoantigen targeted therapies. Cancer neoantigens is a term used to refer to a subset of antigens encoded by tumor-specific, mutated genes, which have not previously been recognized by the host’s immune system.

Market Analysis and Insights: Global Neoantigen Targeted Therapies Market
The global Neoantigen Targeted Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neoantigen Targeted Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neoantigen Targeted Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neoantigen Targeted Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neoantigen Targeted Therapies market.

Global Neoantigen Targeted Therapies Scope and Market Size
Neoantigen Targeted Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neoantigen Targeted Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Combination Therapy

Segment by Application
Medical Research Institution
Hospital and Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bavarian Nordic
Genocea Biosciences
Gradalis
Immunicum
Immunovative Therapies
Iovance Biotherapeutics
MediGene
Neon Therapeutics

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Neoantigen Targeted Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neoantigen Targeted Therapies Market Perspective (2016-2027)
2.2 Neoantigen Targeted Therapies Growth Trends by Regions
2.2.1 Neoantigen Targeted Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neoantigen Targeted Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Neoantigen Targeted Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Neoantigen Targeted Therapies Industry Dynamic
2.3.1 Neoantigen Targeted Therapies Market Trends
2.3.2 Neoantigen Targeted Therapies Market Drivers
2.3.3 Neoantigen Targeted Therapies Market Challenges
2.3.4 Neoantigen Targeted Therapies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neoantigen Targeted Therapies Players by Revenue
3.1.1 Global Top Neoantigen Targeted Therapies Players by Revenue (2016-2021)
3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neoantigen Targeted Therapies Revenue
3.4 Global Neoantigen Targeted Therapies Market Concentration Ratio
3.4.1 Global Neoantigen Targeted Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapies Revenue in 2020
3.5 Neoantigen Targeted Therapies Key Players Head office and Area Served
3.6 Key Players Neoantigen Targeted Therapies Product Solution and Service
3.7 Date of Enter into Neoantigen Targeted Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neoantigen Targeted Therapies Breakdown Data by Type
4.1 Global Neoantigen Targeted Therapies Historic Market Size by Type (2016-2021)
4.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2022-2027)

5 Neoantigen Targeted Therapies Breakdown Data by Application
5.1 Global Neoantigen Targeted Therapies Historic Market Size by Application (2016-2021)
5.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neoantigen Targeted Therapies Market Size (2016-2027)
6.2 North America Neoantigen Targeted Therapies Market Size by Type
6.2.1 North America Neoantigen Targeted Therapies Market Size by Type (2016-2021)
6.2.2 North America Neoantigen Targeted Therapies Market Size by Type (2022-2027)
6.2.3 North America Neoantigen Targeted Therapies Market Size by Type (2016-2027)
6.3 North America Neoantigen Targeted Therapies Market Size by Application
6.3.1 North America Neoantigen Targeted Therapies Market Size by Application (2016-2021)
6.3.2 North America Neoantigen Targeted Therapies Market Size by Application (2022-2027)
6.3.3 North America Neoantigen Targeted Therapies Market Size by Application (2016-2027)
6.4 North America Neoantigen Targeted Therapies Market Size by Country
6.4.1 North America Neoantigen Targeted Therapies Market Size by Country (2016-2021)
6.4.2 North America Neoantigen Targeted Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neoantigen Targeted Therapies Market Size (2016-2027)
7.2 Europe Neoantigen Targeted Therapies Market Size by Type
7.2.1 Europe Neoantigen Targeted Therapies Market Size by Type (2016-2021)
7.2.2 Europe Neoantigen Targeted Therapies Market Size by Type (2022-2027)
7.2.3 Europe Neoantigen Targeted Therapies Market Size by Type (2016-2027)
7.3 Europe Neoantigen Targeted Therapies Market Size by Application
7.3.1 Europe Neoantigen Targeted Therapies Market Size by Application (2016-2021)
7.3.2 Europe Neoantigen Targeted Therapies Market Size by Application (2022-2027)
7.3.3 Europe Neoantigen Targeted Therapies Market Size by Application (2016-2027)
7.4 Europe Neoantigen Targeted Therapies Market Size by Country
7.4.1 Europe Neoantigen Targeted Therapies Market Size by Country (2016-2021)
7.4.2 Europe Neoantigen Targeted Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neoantigen Targeted Therapies Market Size (2016-2027)
8.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type
8.2.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application
8.3.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region
8.4.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neoantigen Targeted Therapies Market Size (2016-2027)
9.2 Latin America Neoantigen Targeted Therapies Market Size by Type
9.2.1 Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Neoantigen Targeted Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2027)
9.3 Latin America Neoantigen Targeted Therapies Market Size by Application
9.3.1 Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Neoantigen Targeted Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2027)
9.4 Latin America Neoantigen Targeted Therapies Market Size by Country
9.4.1 Latin America Neoantigen Targeted Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Neoantigen Targeted Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neoantigen Targeted Therapies Market Size (2016-2027)
10.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type
10.2.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application
10.3.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country
10.4.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Details
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Neoantigen Targeted Therapies Introduction
11.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.1.5 Bavarian Nordic Recent Development
11.2 Genocea Biosciences
11.2.1 Genocea Biosciences Company Details
11.2.2 Genocea Biosciences Business Overview
11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Introduction
11.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.2.5 Genocea Biosciences Recent Development
11.3 Gradalis
11.3.1 Gradalis Company Details
11.3.2 Gradalis Business Overview
11.3.3 Gradalis Neoantigen Targeted Therapies Introduction
11.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.3.5 Gradalis Recent Development
11.4 Immunicum
11.4.1 Immunicum Company Details
11.4.2 Immunicum Business Overview
11.4.3 Immunicum Neoantigen Targeted Therapies Introduction
11.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.4.5 Immunicum Recent Development
11.5 Immunovative Therapies
11.5.1 Immunovative Therapies Company Details
11.5.2 Immunovative Therapies Business Overview
11.5.3 Immunovative Therapies Neoantigen Targeted Therapies Introduction
11.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.5.5 Immunovative Therapies Recent Development
11.6 Iovance Biotherapeutics
11.6.1 Iovance Biotherapeutics Company Details
11.6.2 Iovance Biotherapeutics Business Overview
11.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Introduction
11.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.6.5 Iovance Biotherapeutics Recent Development
11.7 MediGene
11.7.1 MediGene Company Details
11.7.2 MediGene Business Overview
11.7.3 MediGene Neoantigen Targeted Therapies Introduction
11.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.7.5 MediGene Recent Development
11.8 Neon Therapeutics
11.8.1 Neon Therapeutics Company Details
11.8.2 Neon Therapeutics Business Overview
11.8.3 Neon Therapeutics Neoantigen Targeted Therapies Introduction
11.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.8.5 Neon Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details